Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Neumora Therapeutics, Inc. | 21,034 | reported | 17 Feb 2026 | tx 24+1,598,975−790,514 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Feb 2026 | SALE | Neumora Therapeutics, Inc. | 1,436 | 3.57 USD | |
| 08 Jan 2026 | GRANT_AWARD | Neumora Therapeutics, Inc. | 350,000 | 0.00 USD | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 85,391 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 38,234 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 28,675 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 41,250 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 400,000 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 85,391 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 38,234 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 28,675 | — | deriv |
| 28 May 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 41,250 | — | deriv |
| 28 May 2025 | OTHER | Neumora Therapeutics, Inc. | 400,000 | — | deriv |
| 18 Feb 2025 | SALE | Neumora Therapeutics, Inc. | 1,978 | 1.69 USD | |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 28,675 | — | deriv |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 38,234 | — | deriv |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 85,391 | — | deriv |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 400,000 | 0.00 USD | deriv |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 41,250 | — | deriv |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 28,675 | — | deriv |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 38,234 | — | deriv |
| 13 Feb 2025 | GRANT_AWARD | Neumora Therapeutics, Inc. | 85,391 | — | deriv |
| 13 Feb 2025 | OTHER | Neumora Therapeutics, Inc. | 41,250 | — | deriv |
| 14 Feb 2024 | GRANT_AWARD | Neumora Therapeutics, Inc. | 20,625 | 0.00 USD | |
| 14 Feb 2024 | GRANT_AWARD | Neumora Therapeutics, Inc. | 41,250 | 0.00 USD | deriv |